Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis ; volume:16 ; number:1 ; day:3 ; month:10 ; year:2016 ; pages:1-10 ; date:12.2016
BMC psychiatry ; 16, Heft 1 (3.10.2016), 1-10, 12.2016
- Creator
-
De Silva, Varuni Asanka
- Contributor
-
Suraweera, Chathurie
Ratnatunga, Suhashini S.
Dayabandara, Madhubashinee
Wanniarachchi, Nimali
Hanwella, Raveen
SpringerLink (Online service)
- DOI
-
10.1186/s12888-016-1049-5
- URN
-
urn:nbn:de:1111-2016110432817
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- De Silva, Varuni Asanka
- Suraweera, Chathurie
- Ratnatunga, Suhashini S.
- Dayabandara, Madhubashinee
- Wanniarachchi, Nimali
- Hanwella, Raveen
- SpringerLink (Online service)
Other Objects (12)
Antipsychotic Induced Weight Gain and Genetic Variation
Altered gene expression in antipsychotic-induced weight gain
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Risk factors and pattern of weight gain in youths using antipsychotic drugs
Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Weight gain prevention in young adults: design of the study of novel approaches to weight gain prevention (SNAP) randomized controlled trial
Antipsychotic Induced Weight Gain and Genetic Variation
Altered gene expression in antipsychotic-induced weight gain
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Risk factors and pattern of weight gain in youths using antipsychotic drugs
Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Weight gain prevention in young adults: design of the study of novel approaches to weight gain prevention (SNAP) randomized controlled trial
Antipsychotic Induced Weight Gain and Genetic Variation
Altered gene expression in antipsychotic-induced weight gain
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Risk factors and pattern of weight gain in youths using antipsychotic drugs
Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?